← Leaderboards
Leandro C Cerchietti
Weill Medical Coll Of Cornell Univ
$6,986,102
Attributed
$7,183,737
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,219,716 · 6
By mechanism
P01$6,147,922 · 3
R01$5,676,523 · 2
R21$395,271 · 1
Top collaborators
- Christopher R Flowers2 shared
- Ankur Singh2 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Roberta Zappasodi$1,665,977
- Steven Zvi Josefowicz$9,023,527
- Tharu M Fernando$127,140
- Antonio Marzio$472,730
Others in their field
Top investigators on “Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
LymphomaS LymphomaLarge Cell Diffuse Non-Hodgkin&AposBiologyTumorMutationMolecularMalignant NeoplasmsIn VitroPathway InteractionsBiologicalNovel Therapeutic InterventionBiochemicalGeneticMediatingPhenotypeMolecular SubtypesCellsB-LymphocytesGenetic TranscriptionSignal TransductionComplexLymphomagenesisAffect
Grant awards (19)
Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche$2,474,764
P01 · FY2025 · CA · contact PI
Project 3 Cerchietti$407,063
P01 · FY2025 · CA · contact PI
Admin Core$135,058
P01 · FY2025 · CA · contact PI
Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche$2,561,215
P01 · FY2024 · CA · contact PI
Role of BCL10 somatic mutations in lymphomagenesis and response to BCR-targeted therapies$531,919
R01 · FY2024 · CA · contact PI
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape$497,796
R01 · FY2024 · CA · contact PI
Project 3 Cerchietti$419,309
P01 · FY2024 · CA · contact PI
Admin Core$150,513
P01 · FY2024 · CA · contact PI
Role of BCL10 somatic mutations in lymphomagenesis and response to BCR-targeted therapies$545,957
R01 · FY2023 · CA · contact PI
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape$521,432
R01 · FY2023 · CA · contact PI
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape$254,250
R01 · FY2023 · CA · contact PI
Role of BCL10 somatic mutations in lymphomagenesis and response to BCR-targeted therapies$548,714
R01 · FY2022 · CA · contact PI
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape$529,121
R01 · FY2022 · CA · contact PI
Role of BCL10 somatic mutations in lymphomagenesis and response to BCR-targeted therapies$557,099
R01 · FY2021 · CA · contact PI
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape$547,537
R01 · FY2021 · CA · contact PI
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape$575,256
R01 · FY2020 · CA · contact PI
Role of BCL10 somatic mutations in lymphomagenesis and response to BCR-targeted therapies$567,442
R01 · FY2020 · CA · contact PI
(PQD5)Biomaterials-based Adaptive Tumor Microenvironments for In Vitro Drug Scree$215,652
R21 · FY2015 · CA
(PQD5)Biomaterials-based Adaptive Tumor Microenvironments for In Vitro Drug Scree$179,619
R21 · FY2014 · CA